Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

Human Molecular Genetics

Volumn 21, Issue 24, 2012, Pages 5239-5245

  Smith, Miriam J ^a,c   Walker, James A ^a   Shen, Yiping ^a   Stemmer Rachamimov, Anat ^a   Gusella, James F ^a   Plotkin, Scott R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; SMARCB1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILIAL SCHWANNOMATOSIS; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTRON; MISSENSE MUTATION; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN MOTIF; RNA SPLICING; RNA STABILITY; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON;

3' UNTRANSLATED REGIONS; ALLELES; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN D1; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; MUTATION, MISSENSE; NEURILEMMOMA; NEUROFIBROMATOSES; RNA SPLICING; RNA STABILITY; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84870362392     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds370     Document Type: Article

References (17)

1. MacCollin, M., Chiocca, E.A., Evans, D.G., Friedman, J.M., Horvitz, R., Jaramillo, D., Lev, M., Mautner, V.F., Niimura, M., Plotkin, S.R. et al. (2005) Diagnostic criteria for schwannomatosis. Neurology, 64, 1838-1845.
2. MacCollin, M., Willett, C., Heinrich, B., Jacoby, L.B., Acierno, J.S. Jr, Perry, A. and Louis, D.N. (2003) Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology, 60, 1968-1974.
3. Hulsebos, T.J., Plomp, A.S., Wolterman, R.A., Robanus-Maandag, E.C., Baas, F. and Wesseling, P. (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am. J. Hum. Genet., 80, 805-810.
4. Sestini, R., Bacci, C., Provenzano, A., Genuardi, M. and Papi, L. (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum. Mutat., 29, 227-231.
5. Hadfield, K.D., Newman, W.G., Bowers, N.L., Wallace, A., Bolger, C., Colley, A., McCann, E., Trump, D., Prescott, T. and Evans, D.G. (2008) Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J. Med. Genet., 45, 332-339.
6. Boyd, C., Smith, M.J., Kluwe, L., Balogh, A., Maccollin, M. and Plotkin, S.R. (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin. Genet., 74, 358-366.
7. Versteege, I., Sevenet, N., Lange, J., Rousseau-Merck, M.F., Ambros, P., Handgretinger, R., Aurias, A. and Delattre, O. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature, 394, 203-206.
8. Sevenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R. and Delattre, O. (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet., 65, 1342-1348.
9. Swensen, J.J., Keyser, J., Coffin, C.M., Biegel, J.A., Viskochil, D.H. and Williams, M.S. (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J. Med. Genet., 46, 68-72.
10. Eaton, K.W., Tooke, L.S., Wainwright, L.M., Judkins, A.R. and Biegel, J.A. (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr. Blood Cancer, 56, 7-15.
11. Janson, K., Nedzi, L.A., David, O., Schorin, M., Walsh, J.W., Bhattacharjee, M., Pridjian, G., Tan, L., Judkins, A.R. and Biegel, J.A. (2006) Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr. Blood Cancer, 47, 279-284.
12. Patil, S., Perry, A., Maccollin, M., Dong, S., Betensky, R.A., Yeh, T.H., Gutmann, D.H. and Stemmer-Rachamimov, A.O. (2008) Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol. (Zurich, Switzerland), 18, 517-519.
13. Smith, M.J., Boyd, C.D., MacCollin, M.M. and Plotkin, S.R. (2009) Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations. Clin. Genet., 75, 501-502.
14. Jacoby, L.B., MacCollin, M., Parry, D.M., Kluwe, L., Lynch, J., Jones, D. and Gusella, J.F. (1999) Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Neurogenetics, 2, 101-108.
15. Zhang, Z.K., Davies, K.P., Allen, J., Zhu, L., Pestell, R.G., Zagzag, D. and Kalpana, G.V. (2002) Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol. Cell. Biol., 22, 5975-5988.
16. Biegel, J.A., Zhou, J.Y., Rorke, L.B., Stenstrom, C., Wainwright, L.M. and Fogelgren, B. (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res., 59, 74-79.
17. Anderson, M.A. and Gusella, J.F. (1984) Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro, 20, 856-858.